Table 3.
Group | Dose (mg/kg/day) | IGFBPrP1 | Smad3 | FN |
---|---|---|---|---|
| ||||
Normal | — | 0.27±0.04 | 0.21±0.07 | 2.04±0.17 |
Model | — | 0.75±0.08** | 1.04±0.30* | 4.41±2.44 |
CG-V | 15 | 0.35±0.09 | 0.38±0.08 | 0.68±0.34 |
CG-VI | 3 | 0.47±0.17 | 0.19±0.09▲ | 3.54±1.03 |
CG-VII | 6 | 0.26±0.04▲ | 0.33±0.09▲ | 2.32±0.43 |
Positive drug | 8 | 0.37±0.11▲ | 0.54±0.35▲ | 1.80±0.03 |
Compared with the normal group,
P<0.05,
P<0.01; compared with the model group,
P<0.05,
P<0.01
CG-V: ether extract; CG-VI: ethyl acetate extract; CG-VII: n-butyl alcohol extract;TAA: thioacetamide; FN: Fibronectin